Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INM

InMed Pharmaceuticals Inc.

CIK 0001728328 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.66
↑ 0.01 (0.61%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$5.50M
P/E Ratio
-0.65
EPS
-8.36
Dividend Yield
Not covered
52W Position
40%
Beta
0.57

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.80
P/S
Not covered
EV/Revenue
Not covered
ROE
-123.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 40%
$0.57$3.28

Latest Financials

2025-06-30 FY
Revenue
$4.94M
Net Income
-$8.16M
Total Assets
$15.58M
Free Cash Flow
–

Recent news